Banco Santander’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $355K | Sell |
3,922
-467
| -11% | -$39.1K | ﹤0.01% | 426 |
|
|
2026
Q1 | $351K | Hold |
4,389
| – | – | ﹤0.01% | 397 |
|
|
2025
Q4 | $374K | Buy |
4,389
+415
| +10% | +$34.1K | ﹤0.01% | 383 |
|
|
2025
Q3 | $309K | Buy |
+3,974
| New | +$311K | ﹤0.01% | 410 |
|
|
2024
Q4 | – | Sell |
-24,274
| Closed | -$1.6M | – | 469 |
|
|
2024
Q3 | $1.6M | Sell |
24,274
-502
| -2% | -$36.5K | 0.02% | 244 |
|
|
2024
Q2 | $2.29M | Sell |
24,776
-739
| -3% | -$65.4K | 0.03% | 224 |
|
|
2024
Q1 | $2.44M | Sell |
25,515
-71,729
| -74% | -$6.03M | 0.03% | 223 |
|
|
2023
Q4 | $7.41M | Buy |
97,244
+1,911
| +2% | +$133K | 0.09% | 139 |
|
|
2023
Q3 | $6.6M | Buy |
95,333
+9,481
| +11% | +$762K | 0.09% | 139 |
|
|
2023
Q2 | $8.1M | Buy |
85,852
+112
| +0.1% | +$9.73K | 0.11% | 119 |
|
|
2023
Q1 | $7.09M | Buy |
85,740
+11,338
| +15% | +$891K | 0.1% | 103 |
|
|
2022
Q4 | $5.55M | Buy |
74,402
+4,588
| +7% | +$354K | 0.08% | 121 |
|
|
2022
Q3 | $5.77M | Hold |
69,814
| – | – | 0.08% | 127 |
|
|
2022
Q2 | $6.64M | Buy |
+69,814
| New | +$7.23M | 0.09% | 121 |
|
|
2021
Q4 | – | Sell |
-2,319
| Closed | -$263K | – | 427 |
|
|
2021
Q3 | $263K | Buy |
+2,319
| New | +$265K | ﹤0.01% | 386 |
|
|
2021
Q2 | – | Sell |
-3,251
| Closed | -$272K | – | 405 |
|
|
2021
Q1 | $272K | Sell |
3,251
-2,502
| -43% | -$212K | ﹤0.01% | 365 |
|
|
2020
Q4 | $525K | Sell |
5,753
-5,735
| -50% | -$476K | ﹤0.01% | 308 |
|
|
2020
Q3 | $917K | Sell |
11,488
-2,819
| -20% | -$220K | 0.01% | 236 |
|
|
2020
Q2 | $989K | Buy |
14,307
+1,791
| +14% | +$127K | 0.01% | 221 |
|
|
2020
Q1 | $787K | Buy |
12,516
+1,824
| +17% | +$132K | 0.01% | 265 |
|
|
2019
Q4 | $831K | Buy |
+10,692
| New | +$835K | 0.01% | 280 |
|
|
2018
Q4 | – | Sell |
-3,945
| Closed | -$229K | – | 359 |
|
|
2018
Q3 | $229K | Sell |
3,945
-403,806
| -99% | -$19.7M | ﹤0.01% | 343 |
|
|
2018
Q2 | $19.8M | Buy |
407,751
+402,756
| +8,063% | +$18.8M | 0.23% | 63 |
|
|
2018
Q1 | $232K | Sell |
4,995
-160,278
| -97% | -$6.96M | ﹤0.01% | 373 |
|
|
2017
Q4 | $6.21M | Buy |
165,273
+117,273
| +244% | +$4.3M | 0.09% | 88 |
|
|
2017
Q3 | $1.75M | Hold |
48,000
| – | – | 0.03% | 127 |
|
|
2017
Q2 | $1.89M | Buy |
+48,000
| New | +$1.75M | 0.04% | 97 |
|
Other funds holding EW
Banco Santander's EW Position: Q2 2026 in Review
Banco Santander reduced its Edwards Lifesciences (EW) stake by 11% in Q2 2026, selling an estimated $39.1K and leaving 3,922 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #426.
Banco Santander first reported a position in EW in Q2 2017 and has held it in 27 quarters since. The position peaked at $19.8M in Q2 2018. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Banco Santander held 3,922 shares of Edwards Lifesciences worth $355K as of Q2 2026.
- Banco Santander sold 467 Edwards Lifesciences shares in Q2 2026, an estimated $39.1K.
- Edwards Lifesciences made up ﹤0.01% of Banco Santander's portfolio in Q2 2026, its #426 holding.
- Banco Santander first reported a position in Edwards Lifesciences in Q2 2017 and has held it in 27 quarters since.
- Banco Santander's Edwards Lifesciences position peaked at $19.8M in Q2 2018.
- 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.